Prevenar + Infanrix hexa
ApprovedCompleted 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Vaccines, Pneumococcal
Conditions
Vaccines, Pneumococcal, Infant, Fever, Chemically Induced, Drug Therapy, Combination
Trial Timeline
May 1, 2005 → Dec 1, 2006
NCT ID
NCT00294294About Prevenar + Infanrix hexa
Prevenar + Infanrix hexa is a approved stage product being developed by Pfizer for Vaccines, Pneumococcal. The current trial status is completed. This product is registered under clinical trial identifier NCT00294294. Target conditions include Vaccines, Pneumococcal, Infant, Fever, Chemically Induced.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00294294 | Approved | Completed |
Competing Products
20 competing products in Vaccines, Pneumococcal